{"id":15449,"date":"2017-08-08T19:09:34","date_gmt":"2017-08-09T00:09:34","guid":{"rendered":"http:\/\/www.ecuadoraldia.com.ec\/?p=15449"},"modified":"2017-08-08T19:09:34","modified_gmt":"2017-08-09T00:09:34","slug":"un-farmaco-espanol-primer-protector-del-rinon-contra-la-toxicidad-de-los-medicamentos","status":"publish","type":"post","link":"https:\/\/www.ecuadoraldia.com.ec\/?p=15449","title":{"rendered":"Un f\u00e1rmaco espa\u00f1ol, primer protector del ri\u00f1\u00f3n contra la toxicidad de los medicamentos"},"content":{"rendered":"<p><a href=\"http:\/\/www.ecuadoraldia.com.ec\/wp-content\/uploads\/2017\/08\/medicos-espe\u00f1oles.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-15450\" src=\"http:\/\/www.ecuadoraldia.com.ec\/wp-content\/uploads\/2017\/08\/medicos-espe\u00f1oles-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.ecuadoraldia.com.ec\/wp-content\/uploads\/2017\/08\/medicos-espe\u00f1oles-300x200.jpg 300w, https:\/\/www.ecuadoraldia.com.ec\/wp-content\/uploads\/2017\/08\/medicos-espe\u00f1oles.jpg 570w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><br \/>\nUn f\u00e1rmaco espa\u00f1ol, primer protector del ri\u00f1\u00f3n contra la toxicidad de los medicamentos<br \/>\nM\u00e1s de un 40 % de los casos de da\u00f1o renal agudo son producidos por la toxicidad de medicamentos contra el c\u00e1ncer, el sida o infecciones graves, pero investigadores espa\u00f1oles han hallado una mol\u00e9cula completamente inocua capaz de frenar su progresi\u00f3n sin interferir en la efectividad de esos tratamientos.<\/p>\n<p>Se trata de la celastinina, el primer nefroprotector desarrollado en el mundo y que sus creadores, los investigadores del Laboratorio de Fisiopatolog\u00eda Renal del madrile\u00f1o Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Alberto Tejedor y Alberto L\u00e1zaro, conf\u00edan en que pueda usarse ya en los primeros ensayos cl\u00ednicos a partir del a\u00f1o que viene. (I) Fuente EFE<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un f\u00e1rmaco espa\u00f1ol, primer protector del ri\u00f1\u00f3n contra la toxicidad de los medicamentos M\u00e1s de un 40 % de los<\/p>\n","protected":false},"author":1,"featured_media":15450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"_links":{"self":[{"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=\/wp\/v2\/posts\/15449"}],"collection":[{"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15449"}],"version-history":[{"count":1,"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=\/wp\/v2\/posts\/15449\/revisions"}],"predecessor-version":[{"id":15451,"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=\/wp\/v2\/posts\/15449\/revisions\/15451"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=\/wp\/v2\/media\/15450"}],"wp:attachment":[{"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ecuadoraldia.com.ec\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}